Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
70.42
Dollar change
+0.41
Percentage change
0.59
%
IndexS&P 500 P/E259.66 EPS (ttm)0.27 Insider Own1.57% Shs Outstand193.43M Perf Week-5.00%
Market Cap13.63B Forward P/E11.05 EPS next Y6.38 Insider Trans-1.07% Shs Float190.43M Perf Month-2.82%
Income32.62M PEG2.70 EPS next Q1.01 Inst Own95.38% Short Float3.04% Perf Quarter-12.61%
Sales4.24B P/S3.21 EPS this Y414.54% Inst Trans-3.83% Short Ratio3.00 Perf Half Y15.10%
Book/sh17.82 P/B3.95 EPS next Y15.14% ROA0.53% Short Interest5.79M Perf Year18.67%
Cash/sh11.15 P/C6.31 EPS next 5Y96.28% ROE0.76% 52W Range50.35 - 83.95 Perf YTD1.95%
Dividend Est.- P/FCF54.71 EPS past 5Y-40.36% ROI0.93% 52W High-16.12% Beta0.76
Dividend TTM- Quick Ratio1.94 Sales past 5Y14.56% Gross Margin91.09% 52W Low39.86% ATR (14)2.50
Dividend Ex-Date- Current Ratio1.97 EPS Y/Y TTM-88.32% Oper. Margin1.89% RSI (14)45.67 Volatility5.51% 3.18%
Employees2617 Debt/Eq0.02 Sales Y/Y TTM14.76% Profit Margin0.77% Recom2.35 Target Price77.42
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q14.62% Payout0.00% Rel Volume0.97 Prev Close70.01
Sales Surprise3.39% EPS Surprise-5.06% Sales Q/Q16.32% EarningsFeb 10 BMO Avg Volume1.93M Price70.42
SMA20-2.65% SMA50-1.55% SMA2006.33% Trades Volume1,864,637 Change0.59%
Date Action Analyst Rating Change Price Target Change
Dec-17-24Initiated UBS Neutral $77
Oct-29-24Upgrade BofA Securities Neutral → Buy $68 → $90
Oct-01-24Initiated Wolfe Research Outperform $84
Sep-18-24Downgrade Truist Buy → Hold $83 → $74
Jul-02-24Downgrade BMO Capital Markets Market Perform → Underperform $52 → $48
May-23-24Initiated Deutsche Bank Hold $55
Apr-23-24Initiated Cantor Fitzgerald Neutral
Feb-23-24Initiated Jefferies Buy $81
Feb-14-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-23Upgrade Leerink Partners Market Perform → Outperform $78
Feb-11-25 05:55PM
02:04AM
Feb-10-25 11:28PM
05:27PM
04:43PM
02:56PM Loading…
02:56PM
02:47PM
10:38AM
09:30AM
08:15AM
07:30AM
07:23AM
07:00AM
Feb-09-25 08:02AM
Feb-07-25 04:30PM
09:15AM Loading…
Feb-05-25 09:15AM
Feb-03-25 10:00AM
Jan-21-25 08:00AM
Jan-15-25 05:34PM
08:54AM
Jan-13-25 09:40AM
08:30AM
Jan-08-25 06:30PM
Dec-20-24 07:20AM
Dec-17-24 08:00AM
Dec-11-24 06:06PM
Dec-10-24 10:30AM
Dec-09-24 04:46PM
Dec-07-24 07:30AM
Dec-06-24 04:30PM
11:31AM Loading…
Nov-28-24 11:31AM
Nov-26-24 04:10PM
Nov-25-24 10:09AM
Nov-22-24 06:01AM
Nov-20-24 04:31PM
Nov-19-24 04:30PM
04:02PM
12:41PM
12:21PM
12:18PM
11:30AM
06:13AM
Nov-18-24 10:40PM
04:30PM
08:28AM
Nov-16-24 10:06AM
Nov-15-24 07:05PM
Nov-14-24 08:00AM
Nov-07-24 07:22PM
04:30PM
Nov-06-24 06:02AM
Nov-05-24 04:32AM
Oct-30-24 04:37PM
08:00AM
03:03AM
01:05AM
Oct-29-24 04:59PM
04:10PM
12:23PM
12:07PM
09:30AM
08:15AM
07:13AM
07:00AM
Oct-24-24 02:03PM
Oct-17-24 01:02PM
Oct-15-24 08:30AM
Oct-10-24 09:15AM
Oct-08-24 08:00AM
Oct-07-24 11:08PM
Oct-03-24 04:30PM
Sep-25-24 07:00AM
Sep-24-24 09:15AM
Sep-18-24 05:15PM
02:44PM
Sep-16-24 08:27PM
Sep-14-24 12:45PM
10:30AM
Sep-09-24 04:30PM
Aug-29-24 11:31AM
Aug-21-24 11:40AM
Aug-17-24 01:20AM
Aug-16-24 10:33AM
Aug-15-24 04:30PM
12:32PM
10:11AM
08:08AM
Aug-14-24 05:34PM
09:57AM
Aug-13-24 08:00AM
Aug-07-24 05:00PM
Jul-30-24 02:17PM
12:57PM
10:07AM
09:30AM
08:15AM
07:15AM
07:13AM
07:00AM
Jul-24-24 10:26AM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stein Steven HEVP & Chief Medical OfficerJan 21 '25Sale72.6912,352897,86766,967Jan 22 04:05 PM
STEVEN STEINOfficerJan 21 '25Proposed Sale72.6912,352897,906Jan 21 04:03 PM
Tray ThomasPrincipal Accounting OfficerDec 13 '24Sale70.6465045,91623,962Dec 17 12:37 PM
Tray ThomasPrincipal Accounting OfficerDec 16 '24Sale69.3165045,05223,312Dec 17 12:37 PM
THOMAS R TRAYOfficerDec 16 '24Proposed Sale69.3165045,052Dec 16 04:04 PM
Iyengar Vijay KEVP, GMAPPSNov 29 '24Sale75.386,043455,54430,658Dec 03 12:52 PM
VIJAY IYENGAROfficerNov 29 '24Proposed Sale75.396,043455,555Nov 29 01:28 PM
Flannelly Barry PEVP & General Manager USNov 06 '24Option Exercise70.033,680257,71961,722Nov 08 12:48 PM
Flannelly Barry PEVP & General Manager USNov 06 '24Sale79.683,680293,21058,042Nov 08 12:48 PM
BARRY FLANNELLYOfficerNov 06 '24Proposed Sale79.683,680293,210Nov 06 04:15 PM
Tray ThomasPrincipal Accounting OfficerSep 12 '24Sale62.9457236,00224,825Sep 16 01:25 PM
Tray ThomasPrincipal Accounting OfficerSep 13 '24Sale63.3738224,20724,443Sep 16 01:25 PM
Dickinson Jonathan ElliottEVP, General Manager, EuropeSep 12 '24Sale62.368,450526,94836,390Sep 16 01:24 PM
THOMAS R TRAYOfficerSep 13 '24Proposed Sale63.3738224,207Sep 13 04:06 PM
JONATHAN ELLIOTT DICKINSONOfficerSep 12 '24Proposed Sale62.368,450526,930Sep 12 04:17 PM
Stein Steven HEVP & Chief Medical OfficerAug 12 '24Sale60.6311,608703,79390,011Aug 14 03:37 PM
STEVEN STEINOfficerAug 12 '24Proposed Sale60.6311,608703,771Aug 12 04:39 PM
Iyengar Vijay KEVP, GMAPPSJul 25 '24Sale70.0015,5711,089,97036,701Jul 29 03:50 PM
Flannelly Barry PEVP & General Manager USJul 16 '24Sale64.191,30683,83258,042Jul 17 12:24 PM
Flannelly Barry PEVP & General Manager USJul 09 '24Sale60.008,148488,88050,534Jul 11 12:35 PM
Flannelly Barry PEVP & General Manager USJun 12 '24Sale60.0019,1641,149,84066,377Jun 14 12:17 PM
Tray ThomasPrincipal Accounting OfficerJun 06 '24Sale58.911,09364,38921,634Jun 10 12:25 PM
BAKER BROS. ADVISORS LPDirectorMay 07 '24Option Exercise49.0130,0001,470,30033,462,981May 09 06:25 PM